These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28741199)
1. Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients. Xue S; Wang P; Liu J; Chen G World J Surg; 2017 Dec; 41(12):3139-3146. PubMed ID: 28741199 [TBL] [Abstract][Full Text] [Related]
2. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654 [TBL] [Abstract][Full Text] [Related]
3. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis. Back K; Kim JS; Kim JH; Choe JH Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121 [TBL] [Abstract][Full Text] [Related]
4. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients. Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455 [TBL] [Abstract][Full Text] [Related]
5. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma. Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042 [TBL] [Abstract][Full Text] [Related]
7. Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis. Zhao M; Shi X; Zhang J; Deng S; Zhou Y; Wen R; Lu Y; Zhang B Comput Math Methods Med; 2022; 2022():8028846. PubMed ID: 36110571 [TBL] [Abstract][Full Text] [Related]
8. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947 [TBL] [Abstract][Full Text] [Related]
9. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension. Zhang X; Zhang L; Xue S; Wang P; Chen G Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501 [TBL] [Abstract][Full Text] [Related]
10. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients. Wang Y; Guan Q; Xiang J Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Vassilopoulou-Sellin R; Schultz PN; Haynie TP Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396 [TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of prognostic factors predictive of lymph-node metastasis and recurrence in thyroid papillary microcarcinoma. Usluogullari CA; Onal ED; Ozdemir E; Ucler R; Kiyak G; Ersoy PE; Yalcin S; Güler G; Ersoy R; Cakir B Minerva Endocrinol; 2015 Mar; 40(1):15-22. PubMed ID: 24699706 [TBL] [Abstract][Full Text] [Related]
13. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment. Soydal C; Araz M; Ozkan E; Arslantaş E; Kucuk ON; Aras G Nucl Med Commun; 2015 Feb; 36(2):109-13. PubMed ID: 25321158 [TBL] [Abstract][Full Text] [Related]
14. Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS Ann Surg Oncol; 2016 Sep; 23(9):2866-73. PubMed ID: 27075321 [TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma. Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836 [TBL] [Abstract][Full Text] [Related]
16. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting. Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731 [TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis. Hu G; Zhu W; Yang W; Wang H; Shen L; Zhang H World J Surg; 2016 Jan; 40(1):100-9. PubMed ID: 26578322 [TBL] [Abstract][Full Text] [Related]
18. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. Podnos YD; Smith DD; Wagman LD; Ellenhorn JD J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872 [TBL] [Abstract][Full Text] [Related]
19. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study. Gui CY; Qiu SL; Peng ZH; Wang M J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]